GLP1R and chronic kidney disease: Although the current routine use of drugs such as renin angiotensin aldosterone system (RAAS) blockers, SGLT2 inhibitors, and GLP-1 receptor agonists can delay the progression of chronic kidney disease (CKD) to varying degrees [57].